News | December 02, 2023
Venus Remedies granted market authorizations in Saudi Arabia and Philippines
These regulatory approvals signify a significant milestone for Venus Remedies Limited
These regulatory approvals signify a significant milestone for Venus Remedies Limited
The company has raised US$4.5 million in funding for its AI operating system
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
Subscribe To Our Newsletter & Stay Updated
